Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-6015

ABSTRACT: Comparing the transcriptome profiling of ob/ob mice treated with the GLP-1 receptor agonist liraglutide, a clinically used GLP-1 receptor agonist, versus baseline controls

PROVIDER: E-MTAB-6015 | ExpressionAtlas | 2017-11-29

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-6015-analysis-methods.tsv	Tabular
	E-MTAB-6015-analytics.tsv	Tabular
	E-MTAB-6015-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-6015-configuration.xml	Xml
	E-MTAB-6015-g2_g1-mvaPlot.png	Other

Items per page:

1 - 5 of 22

Similar Datasets

Comparing the transcriptome profiling of ob/ob mice treated with the GLP-1 receptor agonist liraglutide, a clinically used GLP-1 receptor agonist, versus baseline controls

Project description:Comparing the transcriptome profiling of ob/ob mice treated with the GLP-1 receptor agonist liraglutide, a clinically used GLP-1 receptor agonist, versus baseline controls

| PRJEB67837 | ENA

Cardiac proteomics in diabetic cardiomyopathy mice treated with GLP-1 receptor agonist

Project description:the changes of cardiac proteomics in diabetic cardiomyopathy mice treated with GLP-1 receptor agonist

2021-09-10 | PXD028452 |

Prostaglandin E2 Receptor Subtype EP2- and EP4-regulated Gene Expression Profiling in Human Ciliary Smooth Muscle Cells

Project description:Changes of genome-wide mRNA transcription levels of human ciliary smooth muscle (hCSM) cells were determined by treating hCSM cells in culture with 200 nM of either an prostaglandin E2 receptor subtype EP2 or subtype EP4 selective agonist for 6 hours in comparison to untreated controls. This was followed by competitive hybridization of fluorescent Cy3 or Cy5 labeled cRNA probes derived from the treated versus untreated control total RNA samples onto an Agilent Human Whole Genome Expression oligonucleotide microarray. Log 2 (LN) of the intra-slide ratios (RATIO, PRE_VALUE) of treated versus untreated samples was reported as VALUE in the sample files. Keywords: prostaglandin E2 receptor agonists, subtype EP2, subtype EP4, hCSM

2008-02-24 | GSE10621 | GEO

β2 adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses

Project description:RNA sequencing of ILC2s sorted from β2 adrenergic receptor agonist-treated and non-treated mice

2018-11-27 | GSE108884 | GEO

Ribosomal protein S3: a functional component of NF-kB p65 binding complexes

Project description:To explore the effects on the NF-kB transcriptome after knockdown of RPS3 in stimulated T cells, we performed microarray assays comparing RPS3-silenced versus NS-treated samples on the same chip. p65-silenced versus NS-treated samples were used as a control. Keywords: time series design

2008-03-01 | GSE7231 | GEO

Mouse kidney mitochondria LC-MS/MS

Project description:ApoE KO mice were treated with Mas receptor agonist AVE 0991 fo 16 weeks. At the age of 6 months mice were killed, the kidneys were dissected and the mitochondria were isolated by differential centrifugation. Next, 2DE electrophoresis was conduced. Healthy control (C57BL/6J mice), apoE KO and apoE KO treated with AVE 0991 were compared. Gel pieces containing protein spots of interest were destained, reduced, alkylated, digested with modified trypsin and analysed by LC-MS/MS method.

2016-05-09 | PXD000233 | Pride

Comparing the cerebellar transcriptome of Sacs KO versus WT mice

Project description:Comparing the cerebellar transcriptome of Sacs KO versus WT mice

| PRJNA827122 | ENA

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Project description:We studied a group of melanoma patients treated with neoadjuvant BRAF/MEK-targeted therapy (NCT02231775, n=51), and observed significantly higher rates of major pathologic response (MPR= <10% viable tumor at resection) and improved recurrence-free survival (RFS) in females versus males (MPR-66% versus 14%, p=0.001; RFS-64% versus 32% at 2 years, p=0.021). Findings were validated in a several additional cohorts 2-4 patients with unresectable metastatic melanoma treated with BRAF and/or MEK-targeted therapy (n=664 patients in total), demonstrating improved progression-free survival (PFS) and overall survival (OS) in females versus males in several of these studies. Studies in pre-clinical models demonstrated significantly impaired anti-tumor activity in male versus female BRAF/MEK-treated mice (p=0.006), with significantly higher expression of androgen receptor (AR) in tumors of male and female BRAF/MEK-treated mice versus control (p=0.0006 and 0.0025). Pharmacologic inhibition of AR signaling improved responses to BRAF/MEK-targeted therapy in male and female mice (p=0.018 and p=0.003), whereas induction of AR signaling (via testosterone administration) was associated with significantly impaired response to BRAF/MEK-targeted therapy in males and females (p=0.021 and p<0.0001).

| EGAS00001006196 | EGA

RNA sequencing of wild type and Thpo deficient hematopoietic stem cells

Project description:RNA sequencing was conducted on up to 5000 CD34-CD150+CD48-LSK cells from Thpo+/+ , Thpo-/- along with Thpo+/+ and Thpo-/- mice treated with 10 days of Thpo receptor agonist (Romiplostim)

2022-11-09 | GSE167004 | GEO

Intellicage analysis of Cpa3+/+ and Cpa3Cre mice

Project description:We investigated antigen-specific avoidance behavior in mice, and found that is critically dependent on mast cells. We interrogated potential signaling routes between mast cells and the brain using mutant mice, pharmacological inhibition of serotonin receptor 3, neural activity recordings, and vagotomy. We analyzed gene expression comparing naive versus immunized wild type mice, and versus mast cell-deficient mice at different times following antigen exposure

2023-06-15 | GSE203209 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data